Skip to main content

Typewise presents new smartphone keyboard

| News

Typewise presents new smartphone keyboard


The startup Typewise is presenting the third generation of its virtual keyboard for smartphones. Typewise 3.0 uses a new patented autocorrect technology.

The keyboard from Typewise for smartphones (img: Typewise)

The tech startup Typewise from Binningen in the canton of Basel-Landschaft presented the third generation of its smartphone keyboard. According to a press release, Typewise 3.0 uses autocorrect technology that has been completely newly developed based on artificial intelligence. The press release states that the app for Android and iOS had been downloaded over a million times in the first year after its introduction. Moreover, Typewise recently won the CES 2021 Innovation Award.

Typewise was the first keyboard to be developed for typing with two thumbs on a smartphone. Traditional smartphone keyboards were developed for typing with ten fingers, which leads to typos according to the press release. Typewise 3.0 uses the new AI-based autocorrect. This produces a quarter of the number of typos. The app can process several languages and can even learn dialects. The press release goes on to say that Typewise 3.0 outperforms well-known apps such as Gboard and SwiftKey. A patent has been registered for the new software. Data protection is ensured as with the previous versions.

The sophisticated autocorrect abilities have been developed and improved along with the speech recognition and the total data protection, according to information provided by Typewise, with the support of the Swiss Federal Institute of Technology in Zurich (ETH).

Typewise Co-Founder and CEO David Eberle views the new version of Typewise as “a great achievement in terms of design, efficiency and precision,” according to the press release. The developers worked closely with the user community “in order to gain a good understanding of what various language users need across the world.” He adds: “Typewise started as a solution to make everyday life easier and to bring an end to irritating typos and awkward typing. Our mission is to change the way we input information into our devices.” Typewise is available for free in the Apple App Store and in the Google Play Store. Premium functions such as speech recognition are available for a fee.

Typewise will participate in the Mobile World Congress in Barcelona as a part of the Swiss National Startup Team from the end of June. This is the world’s largest and most important event for the mobile phone industry. The stay is organized by Venturelab. This is a continuation of Typewise’s success course, after having appeared in the television program “Dragon’s Den Switzerland” where it gained three investors, who took on 15 percent of the overall company shares for an investment of 300,000 Swiss francs according to the website watson. Additionally, Typewise has gained 1 million euros in a seed funding round according to an article on the website EU-Startups.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.